Targeting Cellular Senescence to Extend Healthspan
靶向细胞衰老以延长健康寿命
基本信息
- 批准号:10561620
- 负责人:
- 金额:$ 281.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAgeAgingApoptosisApplications GrantsBiostatistics CoreBlood VesselsCDKN2A geneCell AgingCell CycleCell Differentiation processCell physiologyCellsChromatinChronologyClinicClinical TrialsDNA DamageDiseaseDrug EvaluationDrug usageExtracellular MatrixFoundationsFunctional disorderFutureGeneticGenetic ModelsGeroscienceGoalsGrantHealthHistologyHumanIndividualInflammatoryInvestmentsMeasuresMediatingMediatorMetabolicMetabolic dysfunctionModelingMolecularMusMuscleOutcomePathologyPhenotypePhysiologyPilot ProjectsPrincipal InvestigatorProgram Research Project GrantsProliferatingPropertyProteinsProtocols documentationRat TransgeneResearchResearch PersonnelResistanceRodent ModelRoleScienceSiteSpecificityStructureTechnologyTestingTherapeuticTissuesTransgenic MiceTranslationsVascular Diseasesage relatedagedaging populationbody systembone metabolismcellular targetingchemokinecomorbiditycostcytokinedrug developmentdrug discoverydrug efficacyefficacy testingfirst-in-humanfrailtyhealthspanimprovedinhibitorinnovationmedication safetymultidisciplinarynovelnovel therapeutic interventionparacrinepharmacologicpre-clinicalpreventprogramssenescenceskeletalskeletal muscle wastingstressorsynergismtooltranslational pipeline
项目摘要
OVERALL – PROJECT SUMMARY Khosla/Kirkland
This Program Project Grant (PPG) application reflects the merging of 2 PPGs at the Mayo Clinic Robert and
Arlene Kogod Center on Aging: P01 AG041122 (“Cellular Senescence and Aging,” James Kirkland, PI) and
P01 AG004875 (“Physiology of Bone Metabolism in an Aging Population,” Sundeep Khosla, PI). Over the past
five years, these two research programs have become increasingly aligned. Thus, rather than submitting
separate PPG renewal applications, Drs. Kirkland and Khosla are joining forces as Co-Principal Investigators
in this multi-site application in order to maximize synergies and optimize costs to NIA.
There is now overwhelming evidence that the accumulation of DNA damage and/or other cellular stressors
cause cells to undergo senescence, characterized by profound chromatin changes. Senescent cells can also
develop a senescence-associated secretory phenotype (SASP), comprising pro-inflammatory cytokines,
chemokines, and extracellular matrix-degrading proteins that have deleterious paracrine and systemic effects.
Importantly, key observations made by the investigators in this application have established that reducing the
burden of senescent cells in chronologically-aged mice extended healthspan and improved measures of
metabolic dysfunction, skeletal fragility, vascular dysfunction, and muscle dysfunction/frailty – conditions that
lie at the nexus of the majority of aging co-morbidities. Thus, the overall goal of this multi-disciplinary, multi-
site PPG application is to build a firm foundation of discovery science in cellular senescence that leads to a
pipeline of therapeutic strategies that will slow or prevent age-associated diseases. We have assembled an
investigative team with expertise in evaluating the effects of clearing senescent cells on multiple organ
systems; performing detailed histopathological, molecular, and cellular analyses on the effects of genetic or
pharmacological clearance of senescent cells; and developing novel therapeutic strategies to alter senescent
cell function or burden. We will leverage shared innovative genetic models and cutting-edge investigational
technologies to dissect the tissue- and disease-specific roles of senescent cells in health and disease. The four
projects in this PPG focus on the role of cellular senescence in mediating age-related Metabolic Dysfunction
(Project 1), Skeletal Fragility (Project 2), Vascular Dysfunction (Project 3), and Skeletal Muscle Loss and
Dysfunction (Project 4). These projects will be anchored by 4 cores: Administrative and Biostatistics Core
(Core A); Drug Discovery and Development Core (Core B); Integrated Healthspan Phenotyping Core (Core
C); and Geroscience Pathology and Cellular Histology Core (Core D). This highly integrated PPG will use a
number of common tools and approaches, further underscoring the need for a PPG rather than individual R01
grants. Collectively, the proposed studies will test the Geroscience Hypothesis that targeting a fundamental
aging mechanism, cellular senescence, will delay, prevent, or alleviate multiple age-related disorders.
总体--科斯拉/柯克兰项目摘要
此计划项目拨款(PPG)申请反映了梅奥诊所的2个PPG合并Robert和
阿琳·科戈德老龄化中心:P01 AG041122(《细胞衰老和老龄化》,詹姆斯·柯克兰,PI)和
P01 AG004875(《老龄化人群中的骨代谢生理学》,SunDeep Khosla,PI)。在过去的时间里
五年来,这两个研究项目变得越来越一致。因此,与其提交
独立的PPG续签申请,Kirkland博士和Khosla博士联手担任联合首席调查员
在这种多地点应用,以最大限度地发挥协同作用,并优化成本,以NIA。
现在有压倒性的证据表明DNA损伤和/或其他细胞应激源的积累
导致细胞衰老,其特点是染色质发生深刻变化。衰老的细胞也可以
形成一种衰老相关的分泌表型(SASP),包括促炎细胞因子,
趋化因子和细胞外基质降解蛋白具有有害的旁分泌和全身影响。
重要的是,调查人员在本申请中所做的关键观察已经确定,减少
衰老小鼠衰老细胞负荷延长健康寿命及改进措施
代谢功能障碍、骨骼脆性、血管功能障碍和肌肉功能障碍/脆弱--这些情况
是大多数老年并存疾病的结合点。因此,这一多学科、多领域的总体目标是
现场PPG应用是为细胞衰老的发现科学奠定坚实的基础
将减缓或预防年龄相关疾病的治疗战略的流水线。我们已经组装了一个
具有评估清除衰老细胞对多个器官的影响的专业知识的调查小组
系统;进行详细的组织病理学、分子和细胞分析,以了解遗传或
对衰老细胞的药物清除;以及开发改变衰老的新治疗策略
细胞的功能或负担。我们将利用共享的创新遗传模型和尖端研究
剖析衰老细胞在健康和疾病中特定于组织和疾病的作用的技术。四个
这个PPG项目的重点是细胞衰老在调节年龄相关代谢功能障碍中的作用
(项目1),骨骼脆性(项目2),血管功能障碍(项目3),骨骼肌丢失和
功能障碍(项目4)。这些项目将以4个核心为基础:行政和生物统计核心
(核心A);药物发现和开发核心(核心B);综合Healthspan表型核心(核心
C)和老年科学病理学和细胞组织学核心(核心D)。这款高度集成的PPG将使用
一些常用工具和方法,进一步强调了PPG而不是单个R01的必要性
资助金。总而言之,拟议的研究将检验老年科学假说,该假说针对的是基本的
衰老机制,即细胞衰老,将延缓、预防或缓解多种与年龄相关的疾病。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
- DOI:10.1002/jbmr.4458
- 发表时间:2022-01
- 期刊:
- 影响因子:0
- 作者:Wang H;Zhang Q;Kaplan FS;Pignolo RJ
- 通讯作者:Pignolo RJ
Moderate Exercise Inhibits Age-Related Inflammation, Liver Steatosis, Senescence, and Tumorigenesis.
- DOI:10.4049/jimmunol.2001022
- 发表时间:2021-02-15
- 期刊:
- 影响因子:0
- 作者:Bianchi A;Marchetti L;Hall Z;Lemos H;Vacca M;Paish H;Green K;Elliott B;Tiniakos D;Passos JF;Jurk D;Mann DA;Wilson CL
- 通讯作者:Wilson CL
Epigenetics, DNA damage, and aging.
- DOI:10.1172/jci158446
- 发表时间:2022-08-15
- 期刊:
- 影响因子:15.9
- 作者:Soto-Palma, Carolina;Niedernhofer, Laura J.;Faulk, Christopher D.;Dong, Xiao
- 通讯作者:Dong, Xiao
DNA damage-how and why we age?
- DOI:10.7554/elife.62852
- 发表时间:2021-01-29
- 期刊:
- 影响因子:7.7
- 作者:Yousefzadeh M;Henpita C;Vyas R;Soto-Palma C;Robbins P;Niedernhofer L
- 通讯作者:Niedernhofer L
Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target.
- DOI:10.1007/s11892-022-01493-w
- 发表时间:2022-11
- 期刊:
- 影响因子:4.2
- 作者:Narasimhan, Akilavalli;Flores, Rafael R.;Camell, Christina D.;Bernlohr, David A.;Robbins, Paul D.;Niedernhofer, Laura J.
- 通讯作者:Niedernhofer, Laura J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES L. KIRKLAND其他文献
JAMES L. KIRKLAND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES L. KIRKLAND', 18)}}的其他基金
COVID-FIS: A PHASE 2 PLACEBO-CONTROLLED PILOT STUDY IN COVID-19 OF FISETIN TO ALLEVIATE DYSFUNCTION AND EXCESSIVE INFLAMMATORY RESPONSE IN OLDER ADULTS IN NURSING HOMES
COVID-FIS:针对 COVID-19 的 FISETIN 缓解疗养院老年人功能障碍和过度炎症反应的 2 期安慰剂对照试点研究
- 批准号:
10208138 - 财政年份:2020
- 资助金额:
$ 281.97万 - 项目类别:
Targeting Cellular Senescence to Extend Healthspan
靶向细胞衰老以延长健康寿命
- 批准号:
10349480 - 财政年份:2019
- 资助金额:
$ 281.97万 - 项目类别:
Targeting Cellular Senescence to Extend Healthspan
靶向细胞衰老以延长健康寿命
- 批准号:
10117964 - 财政年份:2019
- 资助金额:
$ 281.97万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 281.97万 - 项目类别:
Operating Grants